Cargando…

A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome

Mitochondrial DNA depletion syndrome (MDS) is a group of severe inherited disorders caused by mutations in genes, such as deoxyribonucleoside kinase (DGUOK). A great majority of DGUOK mutant MDS patients develop iron overload progressing to severe liver failure. However, the pathological mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jingyi, Duan, Lifan, He, Xueying, Li, Shengbiao, Wu, Yi, Xiang, Ge, Bao, Feixiang, Yang, Liang, Shi, Hongyan, Gao, Mi, Zheng, Lingjun, Hu, Huili, Liu, Xingguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132052/
https://www.ncbi.nlm.nih.gov/pubmed/34026460
http://dx.doi.org/10.1002/advs.202004680
_version_ 1783694841339707392
author Guo, Jingyi
Duan, Lifan
He, Xueying
Li, Shengbiao
Wu, Yi
Xiang, Ge
Bao, Feixiang
Yang, Liang
Shi, Hongyan
Gao, Mi
Zheng, Lingjun
Hu, Huili
Liu, Xingguo
author_facet Guo, Jingyi
Duan, Lifan
He, Xueying
Li, Shengbiao
Wu, Yi
Xiang, Ge
Bao, Feixiang
Yang, Liang
Shi, Hongyan
Gao, Mi
Zheng, Lingjun
Hu, Huili
Liu, Xingguo
author_sort Guo, Jingyi
collection PubMed
description Mitochondrial DNA depletion syndrome (MDS) is a group of severe inherited disorders caused by mutations in genes, such as deoxyribonucleoside kinase (DGUOK). A great majority of DGUOK mutant MDS patients develop iron overload progressing to severe liver failure. However, the pathological mechanisms connecting iron overload and hepatic damage remains uncovered. Here, two patients’ skin fibroblasts are reprogrammed to induced pluripotent stem cells (iPSCs) and then corrected by CRISPR/Cas9. Patient‐specific iPSCs and corrected iPSCs‐derived high purity hepatocyte organoids (iHep‐Orgs) and hepatocyte‐like cells (iHep) are generated as cellular models for studying hepatic pathology. DGUOK mutant iHep and iHep‐Orgs, but not control and corrected one, are more sensitive to iron overload‐induced ferroptosis, which can be rescued by N‐Acetylcysteine (NAC). Mechanically, this ferroptosis is a process mediated by nuclear receptor co‐activator 4 (NCOA4)‐dependent degradation of ferritin in lysosome and cellular labile iron release. This study reveals the underlying pathological mechanisms and the viable therapeutic strategies of this syndrome, and is the first pure iHep‐Orgs model in hereditary liver diseases.
format Online
Article
Text
id pubmed-8132052
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81320522021-05-21 A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome Guo, Jingyi Duan, Lifan He, Xueying Li, Shengbiao Wu, Yi Xiang, Ge Bao, Feixiang Yang, Liang Shi, Hongyan Gao, Mi Zheng, Lingjun Hu, Huili Liu, Xingguo Adv Sci (Weinh) Research Articles Mitochondrial DNA depletion syndrome (MDS) is a group of severe inherited disorders caused by mutations in genes, such as deoxyribonucleoside kinase (DGUOK). A great majority of DGUOK mutant MDS patients develop iron overload progressing to severe liver failure. However, the pathological mechanisms connecting iron overload and hepatic damage remains uncovered. Here, two patients’ skin fibroblasts are reprogrammed to induced pluripotent stem cells (iPSCs) and then corrected by CRISPR/Cas9. Patient‐specific iPSCs and corrected iPSCs‐derived high purity hepatocyte organoids (iHep‐Orgs) and hepatocyte‐like cells (iHep) are generated as cellular models for studying hepatic pathology. DGUOK mutant iHep and iHep‐Orgs, but not control and corrected one, are more sensitive to iron overload‐induced ferroptosis, which can be rescued by N‐Acetylcysteine (NAC). Mechanically, this ferroptosis is a process mediated by nuclear receptor co‐activator 4 (NCOA4)‐dependent degradation of ferritin in lysosome and cellular labile iron release. This study reveals the underlying pathological mechanisms and the viable therapeutic strategies of this syndrome, and is the first pure iHep‐Orgs model in hereditary liver diseases. John Wiley and Sons Inc. 2021-03-08 /pmc/articles/PMC8132052/ /pubmed/34026460 http://dx.doi.org/10.1002/advs.202004680 Text en © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Guo, Jingyi
Duan, Lifan
He, Xueying
Li, Shengbiao
Wu, Yi
Xiang, Ge
Bao, Feixiang
Yang, Liang
Shi, Hongyan
Gao, Mi
Zheng, Lingjun
Hu, Huili
Liu, Xingguo
A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
title A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
title_full A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
title_fullStr A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
title_full_unstemmed A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
title_short A Combined Model of Human iPSC‐Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome
title_sort combined model of human ipsc‐derived liver organoids and hepatocytes reveals ferroptosis in dguok mutant mtdna depletion syndrome
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132052/
https://www.ncbi.nlm.nih.gov/pubmed/34026460
http://dx.doi.org/10.1002/advs.202004680
work_keys_str_mv AT guojingyi acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT duanlifan acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT hexueying acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT lishengbiao acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT wuyi acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT xiangge acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT baofeixiang acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT yangliang acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT shihongyan acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT gaomi acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT zhenglingjun acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT huhuili acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT liuxingguo acombinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT guojingyi combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT duanlifan combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT hexueying combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT lishengbiao combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT wuyi combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT xiangge combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT baofeixiang combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT yangliang combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT shihongyan combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT gaomi combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT zhenglingjun combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT huhuili combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome
AT liuxingguo combinedmodelofhumanipscderivedliverorganoidsandhepatocytesrevealsferroptosisindguokmutantmtdnadepletionsyndrome